months, end of June 31, 2019 Financial Statement Consolidate financial statement % revenue from sales Q2/2019 Q2/2018 increase(decrease) Q2/2019 Q2/2018 Revenues from sales 121.53 109.90 11.63 10.58
months, end of June 31, 2019 Financial Statement Consolidate financial statement % revenue from sales Q2/2019 Q2/2018 increase(decrease) Q2/2019 Q2/2018 Revenues from sales 121.53 109.90 11.63 10.58
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as
by Trust receipts facility from purchasing raw material. Secondly is the increase in Account Payable due to an increase in purchasing raw material. 2. Non-current Liabilities As of the year end 2016
and Q2/2018 respectively, An increase in total revenue 20.4% and can be summarized as following. Q-O-Q Change Q2/2017 Q2/2018 Increase/(Decrease) Sales 196.4 240.8 22.6% The sales volume increases as
period last year. The relevant details are as follows:- 1. The Company realized the underwriting profit for the first quarter of 2020 amounted to Baht 11.66 million, an increase of Baht 20.24 million or
the total employers with provident fund or a 34.5 percent increase from the preceding year. The industry was growing significantly and by the end of 2010 the total number of PVD employers had risen to
for the year 2019 of 180 Million Baht increase 123 Million Baht compared with last year (the year 2018, there were profit for the year 57 Million Baht.) Mainly by the increase of Revenue from sales 7
. The assets with major changed were as follows : As of 30 June 2017 total current assets showed Baht 1,279 million, an increase of Baht 51 million or 4.13% increased from year-end 2016. This was mainly
-end 2017. This was mainly due to the increase in both trade accounts receivable and inventory. The trade accounts receivable was increased by Baht 56 million from Baht 612 million in year-end 2017 to be